BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Portfolio holdings
AUM
$924M
This Quarter Return
-1.14%
1 Year Return
+18.54%
3 Year Return
+67.81%
5 Year Return
+208.44%
10 Year Return
+508.52%
AUM
$1.59B
AUM Growth
+$1.59B
(+19%)
Cap. Flow
+$301M
Cap. Flow
% of AUM
18.9%
Top 10 Holdings %
Top 10 Hldgs %
94.23%
Holding
51
New
9
Increased
2
Reduced
5
Closed
9
Top Buys
| 1 |
iShares MSCI EAFE ETF
EFA
|
$128M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$110M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$99.2M |
| 4 |
Light & Wonder
LNW
|
$54.3M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$52.2M |
Top Sells
| 1 |
QuantumScape
QS
|
$54.6M |
| 2 |
Keurig Dr Pepper
KDP
|
$43.3M |
| 3 |
EQT Corp
EQT
|
$27.1M |
| 4 |
AKYA
Akoya BioSciences
AKYA
|
$10.9M |
| 5 |
Upstart Holdings
UPST
|
$4.31M |
Sector Composition
| 1 | Energy | 9.88% |
| 2 | Healthcare | 8.79% |
| 3 | Consumer Discretionary | 7.43% |
| 4 | Communication Services | 6.25% |
| 5 | Consumer Staples | 2.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI Emerging Markets ETF
EEM
$19B
| $406M | 25.51% |
8,313,046
+1,067,670
| +15% | +$52.2M |
|
2
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $344M | 21.63% |
5,752,009
| – | – |
|
|
3
iShares MSCI EAFE ETF
EFA
$66B
| $169M | 10.62% |
2,148,424
+1,620,758
| +307% | +$128M |
|
|
4
EQT Corp
EQT
$32.4B
| $154M | 9.66% |
7,051,112
-1,243,886
| -15% | -$27.1M |
|
|
5
SPDR S&P 500 ETF Trust
SPY
$658B
| $110M | 6.89% |
+231,096
| New | +$110M |
|
|
6
Alphabet (Google) Class A
GOOGL
$2.57T
| $99.2M | 6.23% |
+34,250
| New | +$99.2M |
|
|
7
QuantumScape
QS
$4.49B
| $63.8M | 4.01% |
2,874,742
-2,460,000
| -46% | -$54.6M |
|
8
Kodiak Sciences
KOD
$478M
| $58.6M | 3.68% |
691,767
| – | – |
|
|
9
Light & Wonder
LNW
$7.76B
| $54.3M | 3.41% |
+812,892
| New | +$54.3M |
|
10
Krispy Kreme
DNUT
$608M
| $41.4M | 2.6% |
2,187,760
| – | – |
|
|
AKYA
11
DELISTED
Akoya BioSciences
AKYA
| $28.6M | 1.79% |
1,625,558
-618,217
| -28% | -$10.9M |
|
12
Lyell Immunopharma
LYEL
$213M
| $12.8M | 0.8% |
1,647,882
| – | – |
|
|
LENZ
13
LENZ Therapeutics
LENZ
$1.1B
| $8.74M | 0.55% |
703,071
| – | – |
|
|
DICE
14
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $5.92M | 0.37% |
233,914
| – | – |
|
15
Annexon
ANNX
$226M
| $5.55M | 0.35% |
482,550
| – | – |
|
16
BridgeBio Pharma
BBIO
$9.89B
| $5.53M | 0.35% |
331,283
| – | – |
|
17
Surrozen
SRZN
$104M
| $5.19M | 0.33% |
806,374
| – | – |
|
18
Bolt Biotherapeutics
BOLT
$9.85M
| $3.53M | 0.22% |
719,546
| – | – |
|
19
Doximity
DOCS
$12.7B
| $2.08M | 0.13% |
41,484
| – | – |
|
20
Nautilus Biotechnolgy
NAUT
$85.9M
| $1.6M | 0.1% |
309,492
| – | – |
|
21
Planet Labs
PL
$2.15B
| $1.58M | 0.1% |
+256,445
| New | +$1.58M |
|
22
Black Stone Minerals
BSM
$2.58B
| $1.53M | 0.1% |
147,852
| – | – |
|
23
Kimbell Royalty Partners
KRP
$1.3B
| $1.52M | 0.1% |
111,638
| – | – |
|
24
DigitalOcean
DOCN
$2.97B
| $1.46M | 0.09% |
18,147
-6,049
| -25% | -$486K |
|
25
Douglas Emmett
DEI
$2.71B
| $1.22M | 0.08% |
+36,243
| New | +$1.22M |
|